Antimicrobial Nanocoating

Information

  • Research Project
  • 6882225
  • ApplicationId
    6882225
  • Core Project Number
    R43AI063919
  • Full Project Number
    1R43AI063919-01
  • Serial Number
    63919
  • FOA Number
    PA-02-25
  • Sub Project Id
  • Project Start Date
    4/1/2005 - 19 years ago
  • Project End Date
    9/30/2005 - 19 years ago
  • Program Officer Name
    KORPELA, JUKKA K.
  • Budget Start Date
    4/1/2005 - 19 years ago
  • Budget End Date
    9/30/2005 - 19 years ago
  • Fiscal Year
    2005
  • Support Year
    1
  • Suffix
  • Award Notice Date
    3/28/2005 - 19 years ago

Antimicrobial Nanocoating

DESCRIPTION (provided by applicant): The goals of this SBIR project are to develop an antimicrobial nano-coating (AMNC) in order to address these important problems: 1) prevention of nosocomial infections by treating hand contact surfaces (e.g. door knobs, railings and bathroom fixtures) and improving the microbicidal and biofilm preventative properties of materials used in medical care (e.g. indwelling catheters, central lines, prostheses and other invasive devices); and 2) treating dental and surgical instruments to help prevent infections in non-ideal settings (e.g.3rd world or battlefield) where maintenance of sanitary facilities is extremely difficult. The AMNCs will be deposited from the vapor phase using a plasma-enhanced chemical vapor deposition (PECVD) process onto a variety of surfaces. Development of a viable AMNC requires thorough understanding of the following areas: 1) Deposition of nanometer-scale films via PECVD that contain leachable silver ions. These will be synthesized with at least two different matrix polymers (organic and inorganic) and a range of silver content via inclusion of silver-containing precursors in PECVD process. The bioavailability of the active metal ions will be controlled by providing these nanocoatings with a range of hydrophilicity and nanometer scaled porosity. 2) Establishing antimicrobial effectiveness of silver-containing PECVD films as a function of structure and composition; and 3) investigation of the specific mechanisms by which AMNCs inhibit bacterial growth and biofilm development. Film composition, thickness, and morphology are all controllable by suitable choice of specific reactant gases and deposition conditions. A successful Phase I project will result in the demonstration of a nanometer-scale antimicrobial coating that has been tested on a panel of approximately 20 of the top bacterial pathogens.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R43
  • Administering IC
    AI
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    94056
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    856
  • Ed Inst. Type
  • Funding ICs
    NIAID:94056\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    BRIGHTON TECHNOLOGIES GROUP, INC.
  • Organization Department
  • Organization DUNS
    942982950
  • Organization City
    CINCINNATI
  • Organization State
    OH
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    45217
  • Organization District
    UNITED STATES